Christopher M. DaCosta

LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose

David R. Powell, Melinda Smith, Jennifer Greer et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 181 citations

Improved glycemic control in mice lacking Sglt1 and Sglt2

David R. Powell, Christopher M. DaCosta, Jason Gay et al. · American Journal of Physiology-Endocrinology and Metabolism · 2012 · 157 citations

Metabolic Syndrome, Glucose Tolerance, Energy Homeostasis +14

Novel <scp>l</scp>-Xylose Derivatives as Selective Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes

Nicole C. Goodwin, Ross Mabon, Bryce A. Harrison et al. · Journal of Medicinal Chemistry · 2009 · 76 citations · Full text

Medicinal Chemistry, Diabetes Management, Biochemistry +13

High‐throughput Screening of Mouse Knockout Lines Identifies True Lean and Obese Phenotypes

Robert Brommage, Urvi Desai, Jean‐Pierre Revelli et al. · Obesity · 2008 · 61 citations

Metabolic Disorder, Obesity Prevention, Obesity +18

Requirement for Class II Phosphoinositide 3-Kinase C2α in Maintenance of Glomerular Structure and Function

David P. Harris, Peter Vogel, Marie Wims et al. · Molecular and Cellular Biology · 2010 · 59 citations · Full text

Glomerular Disease, Renal Pathology, Immunology +25